Dr. Andrews Hill’s Ivermectin meta-analysis, from University of Liverpool, England, supported by The Access to COVID-19 Tools (ACT) Accelerator. Presentation from MedinCell Workshop (16 December).
“In conclusion, in this meta-analysis we are seeing using standard WHO grade criteria a faster time to viral clearance, a shorter duration of hospitalisation, 43% higher rates of clinical recovery  and 83% improvement in survival rates ,” said Dr Hill.
 95% C.I. 21-67%
 95% C.I 65-92%